| Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma MV Mateos, MA Dimopoulos, M Cavo, K Suzuki, A Jakubowiak, S Knop, ... New England Journal of Medicine 378 (6), 518-528, 2018 | 1054 | 2018 |
| Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease R Zeiser, N Polverelli, R Ram, SK Hashmi, R Chakraverty, JM Middeke, ... New England Journal of Medicine 385 (3), 228-238, 2021 | 399 | 2021 |
| Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label … PG Richardson, A Oriol, M Beksac, AM Liberati, M Galli, F Schjesvold, ... The Lancet Oncology 20 (6), 781-794, 2019 | 392 | 2019 |
| The outcome of COVID‐19 in patients with hematological malignancy TN Yigenoglu, N Ata, F Altuntas, S Bascı, MS Dal, S Korkmaz, ... Journal of medical virology 93 (2), 1099-1104, 2021 | 146 | 2021 |
| Catheter-related bacteremia due to Kocuria rosea in a patient undergoing peripheral blood stem cell transplantation F Altuntas, O Yildiz, B Eser, K Gündogan, B Sumerkan, M Çetin BMC infectious diseases 4, 1-3, 2004 | 133 | 2004 |
| The role of plasma exchange in HELLP syndrome B Eser, M Guven, A Unal, R Coskun, F Altuntas, M Sungur, IS Serin, I Sari, ... Clinical and applied thrombosis/hemostasis 11 (2), 211-217, 2005 | 124 | 2005 |
| The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning M Güven, M Sungur, B Eser, İ Sarı, F Altuntaş Journal of Toxicology: Clinical Toxicology 42 (5), 617-623, 2004 | 123 | 2004 |
| A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the … I Sari, F Altuntas, S Hacioglu, I Kocyigit, A Sevinc, S Sacar, K Deniz, E Alp, ... American journal of hematology 83 (4), 334-339, 2008 | 101 | 2008 |
| Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study L Kaynar, F Altuntas, I Aydogdu, B Turgut, I Kocyigit, SK Hacıoglu, ... Transfusion and Apheresis Science 38 (2), 109-115, 2008 | 98 | 2008 |
| Convalescent plasma therapy in patients with COVID-19 F Altuntas, N Ata, TN Yigenoglu, S Bascı, MS Dal, S Korkmaz, ... Transfusion and Apheresis Science 60 (1), 102955, 2021 | 92 | 2021 |
| Effects of TSH-suppressive therapy on cardiac morphology and function: beneficial effects of the addition of beta-blockade on diastolic dysfunction S Gullu, F Altuntas, I Dincer, C Erol, N Kamel European journal of endocrinology 150 (5), 655-661, 2004 | 92 | 2004 |
| Dysentery caused by Balantidium coli in a patient with non-Hodgkin’s lymphoma from Turkey S Yazar, F Altuntas, I Sahin, M Atambay World journal of gastroenterology 10 (3), 458, 2004 | 88 | 2004 |
| Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience H Bekoz, M Ozbalak, N Karadurmus, S Paydas, A Turker, T Toptas, ... Annals of Hematology 99, 2565-2576, 2020 | 86 | 2020 |
| Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia S Yazar, O Yaman, B Eser, F Altuntaş, F Kurnaz, I Şahin Journal of medical microbiology 53 (12), 1183-1186, 2004 | 84 | 2004 |
| Laparoscopic versus open splenectomy in the management of benign and malign hematologic diseases: a ten-year single-center experience C Kucuk, E Sozuer, E Ok, F Altuntas, Z Yilmaz Journal of laparoendoscopic & advanced surgical techniques 15 (2), 135-139, 2005 | 83 | 2005 |
| Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma H Akbulut, F Altuntas, KG Akbulut, G Ozturk, M Cindoruk, E Unal, F Icli Cytokine 20 (4), 184-190, 2002 | 83 | 2002 |
| Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study F Altuntas, I Aydogdu, S Kabukcu, I Kocyigit, K Cıkım, I Sarı, MA Erkut, ... Transfusion and Apheresis Science 36 (1), 57-67, 2007 | 82 | 2007 |
| Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis E Kaya, M Keklik, M Şencan, M Yilmaz, A Keskin, I Kiki, MA Erkurt, ... Transfusion and Apheresis Science 48 (3), 349-352, 2013 | 67 | 2013 |
| Overexpression of cyclooxygenase‐2 in multiple myeloma: association with reduced survival M Cetin, S Buyukberber, M Demir, I Sari, I Sari, K Deniz, B Eser, F Altuntas, ... American journal of hematology 80 (3), 169-173, 2005 | 64 | 2005 |
| Convalescent plasma therapy in patients with COVID‐19 TN Yiğenoğlu, T Hacıbekiroğlu, I Berber, MS Dal, A Baştürk, ... Journal of clinical apheresis 35 (4), 367-373, 2020 | 52 | 2020 |
Ali ÜnalErciyes University Medical School Department Hematology在 erciyes.edu.tr 的电子邮件经过验证
